Molecular Partners AG Sponsored ADR (MOLN)
(Delayed Data from NSDQ)
$4.18 USD
+0.30 (7.59%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $4.21 +0.03 (0.72%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 34% (84 out of 248)Zacks Sector Rank
Top 50% (8 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.33 | 1.35 | 9.99 |
Current Quarter Estimate | NA | 2.87 | 57.00 |
Year Ago Quarter Estimate | -0.55 | -5.36 | 52.54 |
Next Quarter Estimate | NA | 7.43 | 61.00 |
Next Year Estimate | -1.96 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -5.71 | 15.30 | 15.67 |
Next Year | 11.71 | 8.80 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 0.73 | 2.15 |
Price/Cash Flow (MRFY) | NA | 17.00 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -864.64% | -164.45% |
Return on Equity (TTM) | -31.42% | -59.04% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.